Intellegens will attend two events focused on oligonucleotides this Spring, where we will discuss progress on our project implementing AI tools to advance manufacturing of oligonucleotide therapeutics.
If you’re attending either event, why not contact us to arrange a meeting?
12th Annual Oligonucleotide Networking Event
25-25 March, Macclesfield
Innovation in Oligonucleotide Manufacturing Symposium
29 April, CPI Medicines Manufacturing Innovation Centre, Glasgow
Project details
Intellegens and the Centre for Process Innovation (CPI), are collaborating to apply machine learning in the emerging field of oligonucleotide therapies. The two-year project is augmenting and validating the Alchemite™, technology from Intellegens as as a tool to enhance productivity and yields of oligonucleotide therapeutic manufacture through performance prediction and optimisation of quality control strategies. Expert support for the project is being provided with direct input from six leading research organisations, including top 10 pharma companies, such as Novartis and specialist biotech companies, such as Silence Therapeutics.
